Tag: MD

Platform-Psychosocial

Living with Multiple Sclerosis: Perceptions, Conflicts and Coping

Background: A physical illness causes pain and suffering to not just the person who is diagnosed but also impacts the lives of family...

Read More

Platform-Disease Management

Treating Minority Patients with Multiple Sclerosis: Development of the CHIMES Trial

Background: Black, African American (AA) and Hispanic/Latino (HA) patients with multiple sclerosis (MS) have greater disease severity and...

Read More

Platform-Psychosocial

The Art of the Patient Conversation: Advanced Practice Provider Perspectives to Improve Outcomes in Multiple Sclerosis

Background: Robust health literacy, defined by the Centers for Disease Control and Prevention as the degree to which an individual can...

Read More

Platform-Neuroimaging

A Description of Real-World MRI Acquired in Patients with Multiple Sclerosis: Preliminary Insights from FlywheelMS

Background: Magnetic resonance imaging (MRI) in the context of routine care is an important tool that can inform clinical decisions in...

Read More

Platform-Neuroimaging

Upper Cervical Spinal Cord Myelin Content and Atrophy across the Spectrum of MS Subtypes

Background: The Canadian Prospective Cohort Study to Understand Progression in People Living with MS (CanProCo) aims to better understand...

Read More

Platform-Psychosocial

Exploring the Impact of the COVID-19 Pandemic on Social Isolation and Mental Health in People with MS

Background: People with Multiple Sclerosis (MS) may be disproportionally impacted by COVID-19 as various factors important to their...

Read More

Platform-Rehabilitation

Stakeholder Recommendations for a Dyadic Physical Activity Intervention for People with Moderate-to-Severe Multiple Sclerosis and Their Care-Partners: A Modified e-Delphi Study.

Background: People with moderate-to-severe multiple sclerosis (MS) and their family caregivers do not engage in sufficient physical...

Read More

Platform-Disease Modifying Therapies

Design of the Phase II, Double-Blind, Placebo-Controlled Dose-Expansion Portion of a Two-Part, Phase I/II, Multicenter Trial in Progressive Multiple Sclerosis

Background: Infection with Epstein-Barr virus (EBV) is a necessary risk factor for the development of multiple sclerosis (MS) Abrahamyan S...

Read More

Platform-Rehabilitation

Spasticity Experience in Adults with Multiple Sclerosis: An Integrated Conceptual Model

Background: Spasticity is a common symptom of multiple sclerosis (MS), often leading to functional limitations and disability. Objectives:...

Read More

Platform-Disease Management

Characterizing Socioeconomic, Lifestyle, and Comorbidity Mediators of Racial Disparities in Ambulatory Impairments in Multiple Sclerosis.

Background: Multiple sclerosis (MS) is more prevalent in White Americans (WAs), yet incidence is now highest in Black Americans (BAs), who...

Read More